G 224 (Lithium Carbonate Extended Release 450 mg)

Pill imprint G 224 has been identified as Lithium carbonate extended release 450 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; mania; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for G 224

Lithium carbonate extended release 450 mg G 224
Lithium carbonate extended release 450 mg G 224
Lithium carbonate extended release
Imprint:
G
224
Strength:
450 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Glenmark Generics Inc.
National Drug Code (NDC):
68462-0224
Inactive Ingredients:
sodium alginate
microcrystalline cellulose
ferric oxide yellow
isopropyl alcohol
magnesium silicate
magnesium stearate
sodium starch glycolate type A potato
hypromelloses

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)